New Delhi: Akums Drugs and Pharmaceuticals has introduced dual-action heartburn relief chewable tablet, combining Famotidine, Calcium Carbonate, and Magnesium Hydroxide.

According to the Company, the product provides both rapid and long-lasting relief for individuals suffering from gastroesophageal reflux disease (GERD) and related symptoms. This formulation is to pair an antacid, which offers immediate neutralization of stomach acid, with Famotidine, a Histamine H2-receptor antagonist that reduces acid production for extended relief.

Sanjeev Jain, MD of Akums Drugs and Pharmaceuticals said, "Heartburn is a widespread issue that affects millions. At Akums, we are dedicated to developing effective solutions for health concerns. Our dual-action chewable tablet is an innovative solution, providing fast, safe, and long-lasting heartburn relief."
Heartburn occurs when gastric acid refluxes into the esophagus, causing discomfort and a burning sensation in the chest.
"Akums’ chewable tablets combine the immediate effects of antacids with the sustained action of H2-receptor antagonists, ensuring relief with lasting benefits. Calcium Carbonate and Magnesium Hydroxide quickly neutralize stomach acid, while Famotidine suppresses gastric acid production to prevent recurrence," as per the release.
Sandeep Jain, MD of Akums, emphasized the importance of this product for the Indian market, "With the rising prevalence of GERD and similar conditions, there is a clear demand for treatments that go beyond temporary relief. Our dual-action chewable tablets offer a comprehensive solution, providing rapid symptom relief and preventing recurrence. We’re proud of our R&D team for this innovative formulation."
The chewable tablet is for short-term symptomatic relief of heartburn and acid regurgitation in adults and adolescents aged 16 and older. Its chewable format ensures convenience and portability, especially for those seeking fast relief while on the go.
Read also: Akums Drugs Secures Patent for Room Temperature Stable Hydroxyurea Oral Suspension for Sickle Cell Disease